title: [Rheumatic diseases need more attention in case of the desire to have children and during pregnancy].
abstract: Treatment of rheumatic diseases, such as rheumatoid arthritis, systemic lupus erythematosus and Bechterew's disease is still improving and the number of fertile patients with a wish to conceive will probably increase. New knowledge regarding the course of rheumatic diseases during pregnancy and post partum herald a change in the support of women with rheumatic diseases who desire to have children. Justified use of antirheumatic drugs before, during and after pregnancy is a key issue for a successful pregnancy. The newer agents such as tumour necrosis factor (TNF) alpha blocking agents can also be of use. Specific preconception care should be offered to women with rheumatic diseases to optimize and increase chances of a successful pregnancy.
authors: Erasmus MC, Afd. Reumatologie, Rotterdam, the Netherlands. y.a.deman@erasmusmc.nl
authors: Yaël A
authors: YA
authors: de Man
authors: Radboud J E M
authors: RJ
authors: Dolhain
authors: Eric A P
authors: EA
authors: Steegers
authors: Johanna M W
authors: JM
authors: Hazes
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D000075202:Contraindications; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008431:Maternal-Fetal Exchange; D016742:Preconception Care / Q000592:standards*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control; D018566:Pregnancy, High-Risk; D012216:Rheumatic Diseases / Q000150:complications* / Q000188:drug therapy / Q000196:embryology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha